The Centers for Disease Control and Prevention yesterday alerted health care providers and the public to reports of severe illness associated with using products containing ivermectin to prevent or treat COVID-19. While ivermectin is approved by the Food and Drug Administration to treat infections caused by parasites, it is not authorized or approved to prevent or treat COVID-19. Dispensing of ivermectin by retail pharmacies and calls to poison control centers involving the drug have increased sharply during the pandemic, however. In some cases, people have ingested products purchased without a prescription, including topical formulations and veterinary products, CDC said. Clinical effects of ivermectin poisoning can range from gastrointestinal symptoms to hypotension and neurological effects.

Related News Articles

Headline
New research from the Center for Disease Control and Prevention indicates that by early fall 2022, an overwhelming percentage of American adults had…
Headline
The Centers for Medicare & Medicaid Services May 31 released regulatory changes to the COVID-19 health care staff vaccination requirements and long-term…
#HealthCareInnovation Blog
In the fall of 2021, two years into the COVID-19 pandemic in the U.S., nearly 80% of adults said they had heard “at least one of eight different false…
Headline
The National Institute for Occupational Safety and Health this week revoked eight N95 filtering facepiece respirator approvals and four powered air-…
Headline
The Centers for Medicare and Medicaid Services released a FAQ regarding Consolidated Appropriations Act changes for states redetermining Medicaid enrollee…
Headline
Telehealth Access for America, an AHA-supported campaign to protect patient access to critical telehealth services, urged Congress to make permanent certain…